Medicxi Growth I LP 13D and 13G filings for Aura Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-11-10 3:21 pm Purchase | 2021-11-02 | 13D | Aura Biosciences, Inc. AURA | Medicxi Growth I LP | 3,039,892 10.700% | 3,039,892 (New Position) | Filing |